Bluejay Diagnostics implements 1-for-4 reverse stock split effective Jan 29, 2026

Bluejay Diagnostics, Inc.

Reverse stock split at 1-for-4 ratio; outstanding shares reduced from ~2,834,133 to ~708,533.
Shares from prefunded warrants reduced from 1,055,000 to 263,750; no fractional shares issued.
Common stock continues trading under symbol 'BJDX' on Nasdaq; new CUSIP 095633608.
Board approved final ratio on Jan 27, 2026; Certificate of Amendment filed with Delaware.

item 3.03 item 5.03 item 5.07 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Bluejay Diagnostics, Inc.: Amended charter to implement a 1-for-4 reverse stock split, effective January 29, 2026 (effective 2026-01-29).

Change: charter amendment
Effective: 2026-01-29

Exact text from the filing

On January 27, 2026, the Company filed a certificate of amendment to the Charter (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware, to implement a 1-for-4 reverse split of the Company’s common stock

View on SEC.gov

83 governance changes filed in the last 30 days. Browse all governance changes →

Bluejay Diagnostics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-009792

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.